Department of Medicine

Tesha Akins
December 17, 2020

Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers

Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.

By VUMC News and Communications
December 17, 2020

Clinic uses new weapon to treat high-risk COVID patients

Vanderbilt University Medical Center has a new weapon in the fight against COVID-19 — an investigational antibody treatment approved last month for emergency use in COVID-19 outpatients at high risk of developing severe disease or requiring hospital care.

By Bill Snyder
December 17, 2020

Clair, Gilbert appointed as vice chairs of Medicine

Kimryn Rathmell, MD, PhD, chair of the Department of Medicine, has announced the appointment of two longtime Vanderbilt faculty members to newly created vice chair roles in the department.

By Paul Govern
December 17, 2020

Study reveals distinct genomic landscape for young adults with appendiceal cancer

The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances for this rare disease.

By Tom Wilemon
Katie Coate, PhD, left, Jeeyeon Cha, MD, PhD, and colleagues are working to understand the interaction of diabetes and COVID-19.
December 10, 2020

Study sheds light on diabetes and COVID interaction

COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.

By Bill Snyder
C. Henrique Serezani, PhD, right, and colleagues, from left, Amondrea Blackman, Nathan Klopfenstein and Júlia Miranda Ribeiro Bazzano are studying the early events of the inflammatory response to infection.
December 10, 2020

Study details early events of inflammatory response

Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.

By Leigh MacMillan
December 3, 2020

Implementation research focus of symposium hosted by VUMC

One hundred ten participants from around the country attended a three-day virtual symposium hosted by Vanderbilt University Medical Center last month that explored how Implementation Research in the Learning Healthcare System can improve the quality and delivery of health care.
By Bill Snyder
December 3, 2020

Six Vanderbilt faculty elected as 2020 fellows of the AAAS

Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers.
By Marissa Shapiro
November 23, 2020

Hot spots identified for colorectal cancer mortality rates among young women

Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology.
By Tom Wilemon
November 18, 2020

Collaborative Vanderbilt Lung Institute launches

By Matt Batcheldor
November 18, 2020

Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer 

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. 
By Bill Snyder
November 18, 2020

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
November 12, 2020

New therapeutic target for lung cancer

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.
By Sarah E. Glass
1 … 43 44 45 46 47 … 104